State WA
Clinical Trials in Washington
Recruiting clinical trials with at least one study location in Washington. Data updated daily from ClinicalTrials.gov.
Top Conditions in Washington
Colorectal Cancer (8)Breast Cancer (7)Prostate Cancer (7)Malignant Solid Neoplasm (6)Acute Myeloid Leukemia (5)Melanoma (5)Non-small Cell Lung Cancer (5)Acute Lymphoblastic Leukemia (4)Ovarian Cancer (4)Hematopoietic and Lymphatic System Neoplasm (4)Mantle Cell Lymphoma (3)Mixed Phenotype Acute Leukemia (3)
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Mod...
Condition
Colitis, Ulcerative
Enrollment
120 pts
Location
United States, Australia, Belgium
Sponsor
Bristol-Myers Squibb
NCT06897475 Phase 2
Recruiting
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes ...
Condition
Type 2 Diabetes
Enrollment
240 pts
Location
United States, Canada, Germany
Sponsor
Eli Lilly and Company
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Me...
Condition
Urothelial Cancer
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT04038502 Phase 2
Recruiting
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Condition
Metastatic Castrate Resistant Prostate Cancer
Enrollment
100 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT05112601 Phase 2
Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System...
Condition
Endometrial Adenocarcinoma
Enrollment
81 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04370301 Phase 2
Recruiting
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or...
Condition
Primary Myelofibrosis
Enrollment
20 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT06448754 Phase 2
Recruiting
Volrustomig Priming Regimens Exploratory Phase II Platform Study
Condition
Non-small Cell Lung Cancer
Enrollment
180 pts
Location
United States, Canada, China
Sponsor
AstraZeneca
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT05304767 Phase 3
Recruiting
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...
Condition
Schizophrenia
Enrollment
280 pts
Location
United States, Bulgaria, Czechia
Sponsor
Karuna Therapeutics, Inc., a B
NCT05544266 N/A
Recruiting
Rare and Atypical Diabetes Network
Condition
Diabetes Mellitus
Enrollment
2,000 pts
Location
United States
Sponsor
University of South Florida
NCT06914596 N/A
Recruiting
A Clinical Trial Comparing Overnight and 2x/Day for 30-minutes Use of the Emanat...
Condition
Periodontitis (Stage 3)
Enrollment
111 pts
Location
United States
Sponsor
McGuire Institute
NCT04910269 Phase 3
Recruiting
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
Condition
COVID
Enrollment
820 pts
Location
United States, Argentina, Australia
Sponsor
University of Minnesota
NCT03779854 Phase 2
Recruiting
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Child...
Condition
Acute Biphenotypic Leukemia
Enrollment
68 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT01193075 N/A
Recruiting
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT...
Condition
Charcot Marie Tooth Disease
Enrollment
5,000 pts
Location
United States, Australia, Canada
Sponsor
Michael Shy
NCT06253871 Phase 1
Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Condition
HER2 Mutation-Related Tumors
Enrollment
243 pts
Location
United States, France, Ireland
Sponsor
Iambic Therapeutics, Inc
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT00843375 N/A
Recruiting
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers ...
Condition
Colonic Neoplasms
Enrollment
1,200 pts
Location
United States, Australia, Canada
Sponsor
University of Michigan Rogel C
NCT05633667 Phase 2
Recruiting
Study of Novel Treatment Combinations in Patients With Lung Cancer
Condition
Lung Cancer
Enrollment
270 pts
Location
United States, Brazil, Hong Kong
Sponsor
Gilead Sciences
NCT05405595 Phase 1, Phase 2
Recruiting
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic So...
Condition
Advanced/Metastatic Solid Tumors
Enrollment
186 pts
Location
United States, China, South Korea
Sponsor
Adagene Inc
NCT06397339 N/A
Recruiting
Indian Transforming Alzheimer's Care Training (INTACT)
Condition
Alzheimer Disease
Enrollment
28 pts
Location
United States
Sponsor
Washington State University
NCT05703971 Phase 1, Phase 2
Recruiting
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SC...
Condition
Small Cell Lung Cancer Extensive Stage
Enrollment
62 pts
Location
United States
Sponsor
Genprex, Inc.
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06637644 N/A
Recruiting
Impella RP Flex with Smart Assist
Condition
Right Ventricular (RV) Dysfunction
Enrollment
200 pts
Location
United States
Sponsor
Abiomed Inc.